BEATRIZE ZAYCO: Open Payments
NPI 1649900952 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$824 in 39 payments from 16 companies in 2025. Trend: 2023 $255 · 2024 $237 · 2025 $824
Food & beverage: $824
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 14 | $291 |
| Sequel Med Tech, LLC | 3 | $83 |
| Abbott Laboratories | 3 | $63 |
| Novo Nordisk Inc | 2 | $53 |
| Radius Health, Inc. | 2 | $48 |
| Xeris Pharmaceuticals, Inc. | 2 | $44 |
| SANOFI-AVENTIS U.S. LLC | 2 | $44 |
| Neurocrine BioSciences, Inc. | 1 | $28 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $27 |
| Tandem Diabetes Care, Inc. | 1 | $26 |
Products named: EVENITY, TWIIST, FREESTYLE LIBRE 3, RECORLEV, TZIELD, Ozempic, CRENESSITY, ISTURISA.
Industry payments across CA — which companies pay providers there.
